EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Omnicell's enterprise value is $1,428 Mil.
Omnicell's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $61 Mil. Therefore, Omnicell's EV-to-EBITDA for today is 23.54.
The historical rank and industry rank for Omnicell's EV-to-EBITDA or its related term are showing as below:
OMCL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.86 Med: 25.7 Max: 58.55
Current: 23.54
During the past 13 years, the highest EV-to-EBITDA of Omnicell was 58.55. The lowest was 11.86. And the median was 25.70.
OMCL's EV-to-EBITDA is ranked worse than 76.3% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.095
vs OMCL: 23.54
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-23), Omnicell's stock price is $28.43.
Omnicell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.450. Therefore, Omnicell's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Omnicell EV-to-EBITDA Historical Data
The historical data trend for Omnicell's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Omnicell's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omnicell EV-to-EBITDA Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Omnicell's EV-to-EBITDA falls into.
Omnicell EV-to-EBITDA Calculation
Omnicell's EV-to-EBITDA for today is calculated as:
Omnicell's current Enterprise Value is $1,428 Mil.
Omnicell's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omnicell (NAS:OMCL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Omnicell's share price for today is $28.43.
Omnicell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.450.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Omnicell's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OMCL has been successfully added to your 